Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2706 A New Possibility in SI-NET Surgery by Using a New β- Probe and 90Y-DOTATOC: A Pilot Study
Introduction: In neuroendocrine tumor (NET), complete surgery could better the prognosis of this disease: radioguided surgery (RGS) with beta-radioisotopes, as 90Y, is a novel approach focused on developing a new probe which, detecting electrons and operating with low background, provides a clearer delineation of the margins of lesions with low radiation exposition for surgeons.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Grana C
Authors: Grana C, Bertani E, Collamati F, Faccini R, Pisa E,
Keywords: Small intestine neuroendocrine tumors, liver metastases, β- probe, 90Y-DOTATOC,
Introduction: The role of primary tumor surgery in pancreatic neuroendocrine tumor (PNET) with unresectable liver metastases is controversial and international guidelines do not recommend surgery in that setting of patients
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Bertani E
Authors: Bertani E, Fazio N, Grana C, Chiappa A, Biffi R,
Keywords: PNET, surgery, liver metastases, distal pancreatectomy, survival,
Introduction: A low burden of disease represents an independent favorable prognostic factor of response to peptide receptor radionuclide therapy (PRRT) in patients affected by gastro-entero-pancreatic neuroendocrine tumors. However it is not clear whether this is due to a lower diffusion of the disease or thanks to debulking surgery
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Bertani E
Authors: Bertani E, Fazio N, Grana C, Bodei L, Funicelli L,
Keywords: PNET, PRRT, debulking surgery, PFS,
Introduction: PRRT with 90Y-octreotide (Y) and 177Lu-octreotate (Lu) is well-tolerated.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Bodei L
Introduction: There are a few case reports on surgery after peptide receptor radionuclide therapy (PRRT).
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Bertani E, Chiappa A, Fazio N, Grana C, Bodei L,
Keywords: neuroendocrine tumors, peptide receptor radionuclide therapy, surgery, survival, progression-free survival,